How Arcutis Biotherapeutics makes money

Period

FY2025

How does Arcutis Biotherapeutics make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Arcutis Biotherapeutics Inc. · FY2025 · year ended 2025-12-31

Revenue$376MNet loss$15M · 4%Cost of revenue$37M · 10%Gross profit$339M · 90%Operating expenses$352M · 93%R&D$77M · 20%SG&A$275M · 73%Other expense$3M · 1%ZORYVE Foam$182M · 48%ZORYVE Cream 0.3$121M · 32%ZORYVE Cream 0.15$68M · 18%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.